NEWARK, Del., March 10, 2026 /PRNewswire/ -- Future Market Insights (FMI) projects the global injectable liquid filling machines market is entering a period of steady expansion as pharmaceutical ...

"I once worked with a guy in his 50s with a PhD in biology who had no idea how to make coffee. He really had no concept of ...

My 2-year-old's condition was extraordinarily rare, affecting fewer than two children in a million, doctors told us.

Assistant Minister for Health Penioni Ravunawa says the rise in HIV cases in Fiji remains a major challenge for the Ministry of Health. In the first six months of 2025 alone, 1,226 new HIV cases were ...

An experiment the results of which would go on to shape drug policy in multiple countries. Countless lives saved. Yet the Mersey Region Drug Training and Information Centre on Maryland Street is ...

The Gibraltar Arts and Crafts Association has donated handmade syringe driver bags for use by palliative care patients, ...

One Boston neighborhood saw a 149 percent increase in needles reported to the city through 311 over the last five years. The post Citywide needle pickup requests fluctuated from 2020 to 2025, but ...

TALLAHASSEE, Fla. – On Thursday, the Florida House voted overwhelmingly to push through its latest tax proposal. That bill — HB 7031 — was originally filed by a committee last week, and it aims to ...

The Gibraltar Arts and Crafts Association has generously donated handmade syringe driver bags for use by palliative care patients, offering both practical support and comfort during treatment in the ...

Stevanato stated that "in 2025, the Nexa syringe was our fastest-growing product, driven primarily by growth from GLP-1s... our revenue from GLP-1s accounted for approximately 19% to 20% of total ...

WARWICK, R.I. — Speaking at times through tears, Scott Naso told a Kent County Family Court judge on Wednesday that he was trying to protect his daughter by keeping her away from her grandparents, who ...

Stevanato Group (NYSE:STVN) executives said the company closed fiscal 2025 with “solid” results and entered 2026 with positive momentum, driven by continued strength in its Biopharmaceutical and Diagn ...